Drug Shortage Report for TEVA-TRIACOMB
Report ID | 240075 |
Drug Identification Number | 00550507 |
Brand name | TEVA-TRIACOMB |
Common or Proper name | TRIACOMB CREAM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | GRAMICIDIN NEOMYCIN NYSTATIN TRIAMCINOLONE ACETONIDE |
Strength(s) | 0.25MG 2.5MG 100000UNIT 1MG |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 30G |
ATC code | D07CB |
ATC description | CORTICOSTEROIDS, COMB WITH ANTIBIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-10-10 |
Estimated end date | 2025-01-10 |
Actual end date | 2025-01-07 |
Shortage status | Resolved |
Updated date | 2025-01-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2025-01-09 | French | Compare |
v7 | 2025-01-09 | English | Compare |
v6 | 2024-12-04 | French | Compare |
v5 | 2024-12-04 | English | Compare |
v4 | 2024-11-28 | French | Compare |
v3 | 2024-11-28 | English | Compare |
v2 | 2024-10-11 | French | Compare |
v1 | 2024-10-11 | English | Compare |
Showing 1 to 8 of 8